mebendazole has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdolahad, M; Alikhani, A; Faramarzpour, M; Hassanpour, M; Namdar, N; Shashaani, H | 1 |
| Rudolf, E; Rudolf, K | 1 |
2 other study(ies) available for mebendazole and cytochrome c-t
| Article | Year |
|---|---|
Silicon nanowire based biosensing platform for electrochemical sensing of Mebendazole drug activity on breast cancer cells.
Topics: Biosensing Techniques; Breast; Breast Neoplasms; Cytochromes c; Drug Screening Assays, Antitumor; Electrochemical Techniques; Female; Humans; MCF-7 Cells; Mebendazole; Nanowires; Silicon; Tubulin Modulators | 2016 |
An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole.
Topics: Aged; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cytochromes c; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mebendazole; Melanoma; Membrane Potential, Mitochondrial; Middle Aged; Mitosis; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2020 |